News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
07 27 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2022 Disability Equality Index® (DEI) Best Places to Work for...
-
07 25 2022 Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients Findings heighten...
-
07 21 2022 Second quarter revenues of $2.45 billion, down 3.8% from 2021 Second quarter reported diluted earnings per share ("EPS") of $1.96, down 60.5% from 2021; and adjusted diluted EPS of $2.36, down...
-
07 19 2022 Testing available at no out-of-pocket cost for qualified insured individuals at Rite Aid drive-thru locations with appointment; at all other Rite Aid locations customers can schedule to pick up at-home specimen collection kits for PCR testingPHILADELPHIA & SECAUCUS, N.J.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing...
-
07 13 2022 Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response Physicians can order the novel Quest Diagnostics lab test beginning today...